Revised Manual on Radiation Oncology Nursing Available

Publication
Article
OncologyONCOLOGY Vol 12 No 2
Volume 12
Issue 2

A revised version of the Manual for Radiation Oncology Nursing Practice and Education is now available from the Oncology Nursing Society (ONS). The revised manual outlines a radiation therapy course and an associated clinical practicum.

A revised version of the Manual for Radiation Oncology Nursing Practice and Education is now available from the Oncology Nursing Society (ONS). The revised manual outlines a radiation therapy course and an associated clinical practicum.

Appropriate utilization of nursing resources in radiation oncology is of major concern due to health care trends for the 1990s that influenced most health care institutions, including departments of radiation oncology, to restructure, reengineer, or downsize. In such an environment, when radiation oncologists plan and direct treatment and radiation therapists deliver treatment, radiation oncology nurses are faced with questions relating to their unique role and whether or not it is cost-effective.

The manual outlines the role of the radiation oncology nurse and the scope of practice, provides recommendations for practice and minimum staffing requirements, and outlines the body of scientific knowledge needed and the art of caring for radiation oncology patients. The manual focuses on assessment, collaborative management, documentation, and patient/family education, and incorporates extensive sections on quality improvement and radiation protection.

The manual is meant to provide a framework for educating the oncology nurse to practice in the radiation ontion oncology patient in any setting. It may be used to define competency measures for staff and to identify nursing resources required to deliver that competent care.

The manual can be purchased for $25 (ONS members) or $30 (nonmembers). To order the manual, contact: ONS Customer Service Department, 501 Holiday Drive, Pittsburgh, PA 15220, or call (412) 921-7373.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
2 experts in this video
Related Content